287 results on '"Sergeant, N."'
Search Results
2. 51 Comparison of proAKAP4 concentrations with motility parameters between fresh and post-thaw Asturcon ponies semen cryopreserved with two different extenders
3. La protéine microtubulaire Tau testiculaire : une place dans la spermatogenèse ?
4. 176 Characterisation of proAKAP4 expression, metabolism, and localisation in
5. Tau exon 2 responsive elements deregulated in myotonic dystrophy type I are proximal to exon 2 and synergistically regulated by MBNL1 and MBNL2
6. L’établissement de normes sériques d’hormone anti-müllerienne (AMH) dans une grande cohorte d’hommes adultes normozoospermiques met la lumière sur de nouvelles potentielles fonctions physiologiques de l’AMH sur la sécrétion de FSH et la mobilité des spermatozoïdes
7. Neurodegenerative Disorders with Tauopathies: Mad Tau Diseases?
8. Cortical Mapping of Pathological Tau Proteins in Several Neurodegenerative Disorders
9. Mis-splicing of Tau exon 10 in myotonic dystrophy type 1 is reproduced by overexpression of CELF2 but not by MBNL1 silencing
10. First results about ProAKAP4 concentration in stallion semen after cryopreservation in two different freezing media
11. A2A adenosine receptor deletion is protective in a mouse model of Tauopathy
12. Overexpression of MBNL1 fetal isoforms and modified splicing of Tau in the DM1 brain: Two individual consequences of CUG trinucleotide repeats
13. Apports de la biologie dans le diagnostic des démences
14. First results about ProAKAP4 concentration in stallion semen after cryopreservation in two different freezing media
15. Frontotemporal dementia, motor neuron disease and tauopathy: clinical and neuropathological study in a family
16. Neurodegenerative Disorders with Tauopathies: Mad Tau Diseases?
17. Tau aggregates are abnormally phosphorylated in inclusion body myositis and have an immunoelectrophoretic profile distinct from other tauopathies
18. Erratum: A2A adenosine receptor deletion is protective in a mouse model of Tauopathy
19. Cortical Mapping of Pathological Tau Proteins in Several Neurodegenerative Disorders
20. Association of atp synthase α-chain with neurofibrillary degeneration in alzheimer’s disease
21. Neurofibrillary Degeneration in Progressive Supranuclear Palsy and Corticobasal Degeneration: Tau Pathologies with Exclusively "Exon 10" Isoforms
22. Neurofibrillary tangles in Gerstmann-Straussler-Scheinker syndrome with the A117V prion gene mutation
23. Two-Dimensional Characterization of Paired Helical Filament-Tau from Alzheimer's Disease: Demonstration of an Additional 74-kDa Component and Age-Related Biochemical Modifications
24. Expression, localization, and concentration of A-kinase anchor protein 4 (AKAP4) and its precursor (proAKAP4) in equine semen: Promising marker correlated to the total and progressive motility in thawed spermatozoa
25. A-kinase anchor protein 4 precursor (pro-AKAP4) in human spermatozoa
26. Significant Correlation Between the proAKAP4 Concentration and the Total and Progressive Motility in Stallion Sperm After Thawing
27. A2A adenosine receptor deletion is protective in a mouse model of Tauopathy
28. Development of a MBNLΔ decoy-based gene therapy for myotonic dystrophy
29. S1-6 Perspectives on potential biomarkers in blood for Alzheimer diagnosis
30. Functional screening of Alzheimer risk loci identifies PTK2B as an in vivo modulator and early marker of Tau pathology
31. Erratum: A2A adenosine receptor deletion is protective in a mouse model of Tauopathy
32. An Environmental Analysis of FCEV And H2-ICE Vehicles using the Ecoscore Methodology
33. Potential reductions of CO 2 emissions due to the landside accessibility of Brussels Airport through adapted policy measures and use of electric vehicles
34. Characterisation of the interaction between amyloid beta 1-42 and glyceraldehyde phosphodehydrogenase
35. P.279 - Development of a MBNLΔ decoy-based gene therapy for myotonic dystrophy
36. Transport. Beleidsaandacht nodig voor milieudruk van lucht- en zeevaart
37. A2A adenosine receptor deletion is protective in a mouse model of Tauopathy
38. Surface-layer Mediated Electrodeposition of Indium-based Nanostructures
39. Similar brain tau pathology in DM2/PROMM and DM1/Steinert disease.
40. Influence of the uptake of electric vehicles on the impact on climate change of an entire future vehicle fleet, a 2020 Brussels perspective
41. Validation of the well-to-wheel approach in the Ecoscore methodology with life cycle assessment for passenger cars
42. Environmental assessment of different vehicle technologies and fuels
43. Environmental breakeven point: an introduction into environmental optimization for passenger car replacement schemes
44. Functional screening of Alzheimer risk loci identifies PTK2B as an in vivo modulator and early marker of Tau pathology
45. Environmental performance of a battery electric vehicle: a descriptive Life Cycle Assessment approach
46. Life Cycle Assessment of conventional and alternative small passenger vehicles in Belgium
47. S.02.04 Physiopathological features of tauopathies and tau transgenic mice
48. C10 Modèles expérimentaux de la pathologie Tau
49. P1-20 Effets de l’exercice volontaire à long terme dans un modèle de souris transgénique THY-Tau22 développant une pathologie Tau similaire à celle observée dans la maladie d’Alzheimer
50. P1-21 Mécanismes sous jacents à l’immunothérapie anti-Tau dans la maladie d’Alzheimer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.